SEC FORM 3

SEC FORM 3SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Goren Ilan

(Last)

(First)

(Middle)

C/O ENLIGHT RENEWABLE ENERGY LTD.

13 AMAL ST. AFEK INDUSTRIAL PARK

(Street)

ROSH HA'AYIN

4802949

(City)

(State)

(Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Enlight Renewable Energy Ltd. [ ENLT ]

3a. Foreign Trading Symbol
[ENLT]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	GENERAL MANAGER, ENLIGHT US

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary shares, NIS 0.1 par value per share	42,835⁽¹⁾	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Options (right to buy)	⁽²⁾	09/30/2028	Ordinary shares, NIS 0.1 par value per share	65,000	$23.22⁽³⁾	D
Stock Options (right to buy)	⁽⁴⁾	06/28/2029	Ordinary shares, NIS 0.1 par value per share	100,000	$22.17⁽⁵⁾	D
Stock Options (right to buy)	⁽⁶⁾	07/29/2032	Ordinary shares, NIS 0.1 par value per share	98,743	$27.33⁽⁷⁾	D

Explanation of Responses:

1. Consists of (i) 21,125 restricted share units granted on April 21, 2024, with 7,042 vesting on each of April 21, 2026 and April 21, 2028, and 7,041 vesting on April 21, 2027; and (ii) 21,710 restricted share units granted on July 29, 2025, with 5,427 vesting on each of October 1, 2026 and October 1, 2028, and 5,428 vesting on each of October 1, 2027 and October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

2. Stock options were granted on September 30, 2021, with 35,000 having vested on September 30, 2024; and 30,000 having vested on September 30, 2025.

3. Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.

4. Stock options were granted on June 28, 2022, with 25,000 having vested on each of June 28, 2023 and June 28, 2024; 35,000 having vested on June 28, 2025; and 15,000 vesting on June 28, 2026.

5. Represents an exercise price of NIS 68.64, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.

6. Stock options were granted on July 29, 2025, with 24,685 vesting on October 1, 2026; and 24,686 vestin on each of October 1, 2027, October 1, 2028, and October 1, 2029.

7. Represents an exercise price of NIS 84.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.

Remarks:

Exhibit 24 - Power of Attorney by Ilan Goren

	By: /s/ Helit Megido as attorney-in-fact for Ilan Goren	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

SEC Form 3 filed by new insider Goren Ilan